Kazakhstan
6 Vaccines Approved for Use in Kazakhstan
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: astanatimes.com
Non Replicating Viral Vector
Gamaleya
Sputnik Light
Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Inactivated
Research Institute for Biological Safety Problems (RIBSP)
QazVac
Approved in 2 countries
3 trials in 1 country
Approval Source: reuters.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
29 trials in 12 countries
Approval Source: astanatimes.com
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries
Approval Source: astanatimes.com
2 in Clinical Trials in Kazakhstan
Inactivated
Research Institute for Biological Safety Problems (RIBSP)
QazVac
Approved in 2 countries
3 trials in 1 country
Protein Subunit
Research Institute for Biological Safety Problems
QazCoVac-P
2 trials in 1 country